overreaction – Finance News

Tylenol maker’s stock lost billions after a rumor linking the medicine to autism. Wall Street says buy the dip as one bank sees a ‘major overreaction’

No Comments

This week, Kenvue, the consumer health spin-off from Johnson & Johnson, found itself at the epicenter…